Cargando…
Mitoxantrone Induces Natural Killer Cell Maturation in Patients with Secondary Progressive Multiple Sclerosis
Mitoxantrone is one of the few drugs approved for the treatment of progressive multiple sclerosis (MS). However, the prolonged use of this potent immunosuppressive agent is limited by the appearance of severe side effects. Apart from its general cytotoxic effect, the mode of action of mitoxantrone o...
Autores principales: | Chanvillard, Coralie, Millward, Jason M., Lozano, Marta, Hamann, Isabell, Paul, Friedemann, Zipp, Frauke, Dörr, Jan, Infante-Duarte, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387260/ https://www.ncbi.nlm.nih.gov/pubmed/22768101 http://dx.doi.org/10.1371/journal.pone.0039625 |
Ejemplares similares
-
The Role of Natural Killer Cells in Multiple Sclerosis and Their Therapeutic Implications
por: Chanvillard, Coralie, et al.
Publicado: (2013) -
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1
por: Janssen, Antonia, et al.
Publicado: (2015) -
Cardiotoxicity of Mitoxantrone Treatment in a German Cohort of 639 Multiple Sclerosis Patients
por: Fleischer, Vinzenz, et al.
Publicado: (2014) -
Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in Neuroinflammation
por: Herges, Katja, et al.
Publicado: (2011) -
Magnetic resonance elastography reveals altered brain viscoelasticity in experimental autoimmune encephalomyelitis()
por: Riek, Kerstin, et al.
Publicado: (2012)